Cryptotanshinone directly binds to PKM2, inhibiting its expression in ovarian cancer cells, thereby suppressing both aerobic glycolysis and oxidative phosphorylation (OXPHOS), leading to cell growth inhibition and apoptosis induction (138). Here, PKM is linked to ovarian carcinoma.